Valiant Laboratories Limited (VALIANTLAB) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE0JWS01017
Key metrics
- Market Cap
- ₹523 Cr
- P/E Ratio
- 32.55
- EPS
- 2.96
- Book Value
- 57.24
- P/B Ratio
- 1.79
- ROE
- -1.05%
- ROCE
- 0.1%
- Debt / Equity
- 0.15
- Net Margin
- -1.38%
- Revenue Growth
- 78.04%
- Profit Growth
- -48.46%
- Dividend Yield
- —
- 52W High
- ₹110.70
- 52W Low
- ₹49.51
- Market Cap Band
- small cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Valiant Laboratories Limited
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 76.78%
The full Valiant Laboratories Limited analysis
Create a free account to open the complete VALIANTLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.